<DOC>
	<DOCNO>NCT01852968</DOCNO>
	<brief_summary>The hippocampus area brain play essential role learn memory processing think particularly vulnerable effect hypoglycemia ( low blood glucose ) . The goal project examine hippocampal neurochemistry metabolism identify diabetes recurrent hypoglycemia alter hippocampus .</brief_summary>
	<brief_title>Hippocampal Metabolism Function Patients With Type 1 Diabetes</brief_title>
	<detailed_description>In study examine hippocampal neurochemical profile glucose transport kinetics use magnetic resonance spectroscopy ( MRS ) patient type 1 diabetes hypoglycemia unawareness match healthy control . We also examine hippocampal function subject group euglycemia hypoglycemia correlate finding change neurochemical profile glucose transport kinetics . Study protocol MRS experiment On morning MRS experiment , subject present Center Magnetic Resonance Research ( CMRR ) 7 AM fast state participate protocol group significant experience . After arrival , prepare clamp study placement one intravenous catheter one vein antecubital fossa later infusion glucose , insulin , potassium . A second intravenous catheter place retrograde vein distal leg later blood sample . An intravenous infusion insulin start adjust necessary bring blood glucose 95 mg/dl . Blood collect every 10 minute measurement glucose nearby Analox machine guide adjustment insulin infusion rate . The experiment begin subject 95 mg/dl . At time 0 , intravenous insulin infusion fix 1 mU/kg/min , sample blood glucose collect every 5 minute intravenous infusion glucose ( 20 % dextrose ) administer necessary maintain blood glucose 95 mg/dl . At +5 minute , subject place magnet . Blood glucose maintain 95 mg/dl next 25 minute hippocampal volume-of-interest ( VOI ) select baseline MRS data acquire . At + 30 min , subject give intravenous bolus injection glucose 1-2 minute use formula administer 2 mg glucose/kg body weight 1 mg/dl increase desire group use success previously . Immediately bolus injection , continuous infusion 20 % dextrose start rate administration adjust maintain desire glucose target 200 mg/dl , 300 mg/dl , 400 mg/dl . MRS data collect continuously start 10 minute bolus injection ( baseline ) end study ~60 minute bolus , sufficient reach steady-state glucose concentration brain maintain least 20 minute . At completion study , infusion discontinue ; subject resume usual insulin regimen , feed meal . The subject diabetes prepared protocol instruct manage diabetes way minimize amount subcutaneous insulin present time study without create hyperglycemia day study ( i.e . pump patient stop pump arrival , glargine treat patient take last glargine dose 24 hour study start ) . At conclusion study , subject allow resume usual insulin regimen . Neurocognitive test On morning Neurocognitive testing , subject present Clinical Translational Science Institute 7 AM fast state . Subjects diabetes blood glucose check ensure blood glucose 90-200 mg/dl . If blood glucose target range , treatment give correct glucose study reschedule . Subjects undergo neurocognitive test California Verbal Learning Test - Second Edition ( CVLT-II ) subtests Repeatable Battery Assessment Neuropsychological Status ( RBANS ) : Story Memory ( immediate delay ) , Digit Span , Coding . After completion neurocognitive testing , intravenous catheter place antegrade forearm subsequent infusion blood sampling . Insulin infuse rate 2.0 mU/kg/min along potassium phosphate ( 4 mEq/hour ) blood glucose reduce maintain 55 mg/dl variable infusion 20 % dextrose . Samples blood glucose collect every 5 minute measurement glucose . Once blood glucose target 55 achieve subject undergo neurocognitive testing . At completion neurocognitive test subject feed euglycemia restore .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>diagnosis type 1 diabetes , hemoglobin A1C &lt; 9 % . Alternatively , subject healthy control . Exclusion criterion group subject include history stroke , seizure , neurosurgical procedure , arrhythmia , use drug alter glucose metabolism ( insulin patient diabetes ) . Subjects must also meet requirement study magnet , include weight le 300 lb . absence metallic substance body .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hypoglycemia</keyword>
	<keyword>hypoglycemia unawareness</keyword>
	<keyword>type 1 diabetes , hippocampus</keyword>
	<keyword>glucose transport</keyword>
	<keyword>cognitive dysfunction</keyword>
</DOC>